Clinical Trials Directory

Trials / Completed

CompletedNCT06762938

The Effect of ShotBlocker on Pain and Satisfaction During Measles-Rubella-Mumps Vaccination

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Yuzuncu Yil University · Academic / Other
Sex
All
Age
12 Months – 12 Months
Healthy volunteers
Accepted

Summary

Objective The aim of this study was to evaluate the effects of ShotBlocker administration during measles-mumps-rubella (MMR) vaccination on infants' pain level and mothers' satisfaction. Method. The study was conducted in a Family Health Center affiliated to the Public Health Directorate of a province in eastern Turkey between August and October 2024 using a randomized controlled experimental design. The study sample consisted of 60 infants who received MMR vaccination (ShotBlocker group: n = 30, control group: n = 30). Infants in the ShotBlocker group received ShotBlocker before vaccine injection, while infants in the control group received only routine vaccine injection. Infant information form, FLACC pain scale and Newcastle Satisfaction with Nursing Care Scale were used for data collection. Ethical principles were followed throughout the study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALShotBlockerApply ShotBlocker

Timeline

Start date
2024-08-01
Primary completion
2024-11-20
Completion
2024-11-30
First posted
2025-01-08
Last updated
2025-01-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06762938. Inclusion in this directory is not an endorsement.